Novo Nordisk is a Danish triple bottom line healthcare company that was founded in 1923 by a Nobel-prize winning scholar at the University of Copenhagen. Novo Nordisk is dedicated to promoting bioethical awareness, integrating environment assessments into all considerations across the value chain, and making their products available to those who need them as well as contributing to the development of sustainable healthcare infrastructure.
Novo Nordisk is passionate about its dedication to balancing social, financial, and environmental considerations, and as a testament to that they were recently recognized with the 2012 TakeAction award, which recognized their commitment to ensuring a steady supply of insulin and other medicines their manufacture to Syria in the country's time of chaos.
Novo Nordisk website
Novo Nordisk on Facebook
Novo Nordisk on Twitter